Do CA125 response criteria overestimate tumour response in second-line treatment of epithelial ovarian carcinoma?GRONLUND, B; HANSEN, H. H; HØGDALL, C et al.British journal of cancer. 2004, Vol 90, Num 2, pp 377-382, issn 0007-0920, 6 p.Article

Second-line chemotherapy in patients with primary unknown cancerONO, Makiko; ANDO, Masashi; YONEMORI, Kan et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 8, pp 1185-1191, issn 0171-5216, 7 p.Article

Re-treatment of Children With Chronic Hepatitis C Who Did Not Respond to Interferon-α TreatmentGERNER, Patrick; HILBICH, Juliane; WENZL, Tobias G et al.Journal of pediatric gastroenterology and nutrition. 2010, Vol 51, Num 2, pp 187-190, issn 0277-2116, 4 p.Article

Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatmentMANCUSO, Andrea; DI PAOLA, Eugenio Donato; CARISTO, Rita et al.BJU international (Papier). 2012, Vol 109, Num 2, pp 200-206, issn 1464-4096, 7 p.Article

A Combined Therapy with Docetaxel and Nedaplatin for Relapsed and Metastatic Esophageal CarcinomaMATSUMOTO, Hideo; HIRABAYASHI, Yoko; KUBOTA, Hisako et al.Anticancer research. 2012, Vol 32, Num 5, pp 1827-1831, issn 0250-7005, 5 p., aArticle

Improving second-line therapy in aggressive non-Hodgkin's lymphomaGISSELBRECHT, Christian; MOUNIER, Nicolas.Seminars in oncology. 2004, Vol 31, pp 12-16, issn 0093-7754, 5 p., SUP2Article

How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatmentGHANIMA, Waleed; GODEAU, Bertrand; CINES, Douglas B et al.Blood. 2012, Vol 120, Num 5, pp 960-969, issn 0006-4971, 10 p.Article

A Review of Second- line Chemotherapy and Prognostic Models for Disseminated Germ Cell TumorsVOSS, Martin H; FELDMAN, Darren R; BOSL, George J et al.Hematology/oncology clinics of North America. 2011, Vol 25, Num 3, issn 0889-8588, viii-ix, 557-576 [22 p.]Article

Complete response of metastatic cutaneous squamous cell carcinoma to cetuximab plus paclitaxelMECCA, Caterina; PONZETTI, Agostino; CALIENDO, Virginia et al.EJD. European journal of dermatology. 2012, Vol 22, Num 6, pp 758-761, issn 1167-1122, 4 p.Article

A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication)MARIN, Alicia C; MCNICHOLL, Adrian G; GISBERT, Javier P et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 7, pp 843-861, issn 1465-6566, 19 p.Article

Neutralizing Antibodies to Interferon-α and Circulating Interferon in Patients With Chronic Hepatitis C Non-Responding to Pegylated Interferon Plus Ribavirin Re-Treated by Pegylated Interferon-α-2a and Ribavirin (ANRS HC16 GAMMATRI Substudy^* )HALFON, Philippe; PERUSAT, Sophie; CHENE, Geneviève et al.Journal of medical virology. 2010, Vol 82, Num 12, pp 2027-2031, issn 0146-6615, 5 p.Article

Prospective Comparison of Sorafenib and Sunitinib for Second-Line Treatment of Cytokine-Refractory Kidney Cancer PatientsHERRMANN, Edwin; BIERER, Stefan; GERSS, Joachim et al.Oncology. 2008, Vol 74, Num 3-4, pp 216-222, issn 0030-2414, 7 p.Article

The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patientsHOCHHAUS, Andreas; KANTARJIAN, Hagop.Journal of cancer research and clinical oncology. 2013, Vol 139, Num 12, pp 1971-1984, issn 0171-5216, 14 p.Article

A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research GroupKONTOPODIS, Emmanouil; HATZIDAKI, Dora; VARTHALITIS, Ioannis et al.Journal of chemotherapy (Testo stampato). 2013, Vol 25, Num 1, pp 49-55, issn 1120-009X, 7 p.Article

A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancerSEHOULI, Jalid; CAMARA, Oumar; MAHNER, Sven et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 5, pp 861-868, issn 0344-5704, 8 p.Article

Clinical and Molecular Determinants of Survival in Pancreatic Cancer Patients Treated with Second-line Chemotherapy: Results of an Italian/Swiss Multicenter SurveyMANCUSO, A; SACCHETTA, S; RECINE, F et al.Anticancer research. 2010, Vol 30, Num 10, pp 4289-4295, issn 0250-7005, 7 p.Article

Phase II Study of Weekly Paclitaxel as a Second-line Treatment for S-1-refractory Advanced Gastric CancerMATSUDA, Goro; KUNISAKI, Chikara; KOSAKA, Takashi et al.Anticancer research. 2009, Vol 29, Num 7, pp 2863-2867, issn 0250-7005, 5 p.Article

Pegylated Liposomal Doxorubicin as Second-line Therapy in the Treatment of Patients With Advanced Classic Kaposi Sarcoma : A Retrospective StudyDI LORENZO, Giuseppe; DI TROLIO, Rossella; MONTESARCHIO, Vincenzo et al.Cancer. 2008, Vol 112, Num 5, pp 1147-1152, issn 0008-543X, 6 p.Article

Phase II study of weekly paclitaxel in Patients with non-small cell lung cancer who have failed previous treatmentsYASUDA, Kazuhito; IGISHI, Tadashi; YAMAMOTO, Mistunobu et al.Oncology. 2004, Vol 66, Num 5, pp 347-352, issn 0030-2414, 6 p.Article

Predictors of failure of first-line antiretroviral therapy in HIV-infected adults : Indian experienceRAJASEKARAN, Sikhamani; JEYASEELAN, Lakshmanan; VIJILA, Sundaraj et al.AIDS (London). 2007, Vol 21, issn 0269-9370, S47-S53, SUP4Conference Paper

Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine : a multicenter randomised phase II studyGEORGOULIAS, V; AGELIDOU, A; KALBAKIS, K et al.British journal of cancer. 2005, Vol 93, Num 7, pp 763-769, issn 0007-0920, 7 p.Article

Sequential topotecan and oral etoposide in recurrent ovarian carcinoma pretreated with platinum-taxane : Results from a multicenter phase I/II studyGRONLUND, Bo; ENGELHOLM, Svend A; HORVATH, Gyorgy et al.Cancer. 2005, Vol 103, Num 7, pp 1388-1396, issn 0008-543X, 9 p.Article

Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trialRAVAUD, A; TRUFFLANDIER, N; FERRIERE, J. M et al.British journal of cancer. 2003, Vol 89, Num 12, pp 2213-2218, issn 0007-0920, 6 p.Article

Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South AfricaLEVISON, Julie H; ORRELL, Catherine; LOSINA, Elena et al.Antiviral therapy (London). 2011, Vol 16, Num 6, pp 853-861, issn 1359-6535, 9 p.Article

Front-Line Therapy With Second-Generation Tyrosine Kinase Inhibitors in Patients With Early Chronic Phase Chronic Myeloid Leukemia: What Is the Optimal Response?JABBOUR, Elias; KANTARJIAN, Hagop M; O'BRIEN, Susan et al.Journal of clinical oncology. 2011, Vol 29, Num 32, pp 4260-4265, issn 0732-183X, 6 p.Article